INTERNATIONAL PATENT: IOMX THERAPEUTICS AG FILES APPLICATION FOR "A HALOGENATED-HETEROARYL KINASE INHIBITOR FOR TREATING SOFT TISSUE SARCOMA AND VASCULAR TUMORS"

GENEVA, Nov. 10 -- IOMX THERAPEUTICS AG (FraunhoferstraBe 2282152 Martinsried) filed a patent application (PCT/EP2025/061968) for "A HALOGENATED-HETEROARYL KINASE INHIBITOR FOR TREATING SOFT TISSUE SARCOMA AND VASCULAR TUMORS" on Apr 30, 2025. With publication no. WO/2025/229127, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MASER, Petra (c/o iOmx Therapeutics AGFraunhoferstraBe 2282152 Martinsried), LOFERER, Hannes (c/o iOmx Therapeutics AGFraunhoferstraBe 2282152 Martinsried), YULE, Murray (c/o iOmx Therapeutics AGFra...